GE HealthCare Technologies Inc.
GEHC· Nasdaq
GEHCGE HealthCare Technologies Inc.
Quarterly figures for GE HealthCare Technologies Inc., with source filings when available.
18 quarters. Mar 31, 2022 to Jun 30, 2026. USD.
GE HealthCare Technologies Inc. has filed its 10-Q within 29 to 31 days of period end across its last 8 quarters. The 10-K runs 35 to 46 days.
GE HealthCare Technologies Inc. · CIK 1932393 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Jul 29, 2026 · pre-market | Jul 29, 2026 | 29 d | 10-Q | $5.30B | +5.8% | $1.24 | |
| Q1 2026 | Mar 31, 2026 | Apr 29, 2026 · pre-market | Apr 29, 2026 | 29 d | 10-Q | ||||
| FY 2025 | |||||||||
| Q4 2025derived | Dec 31, 2025 | Feb 4, 2026 · pre-market | Feb 4, 2026 | 35 d | 10-K | $5.70B | +7.1% | — | |
| Q3 2025 | Sep 30, 2025 | Oct 29, 2025 · pre-market | Oct 29, 2025 | ||||||
| FY 2024 | |||||||||
| Q4 2024derived | Dec 31, 2024 | Feb 13, 2025 · pre-market | Feb 13, 2025 | 44 d | 10-K | $5.32B | +2.2% | — | |
| Q3 2024 | Sep 30, 2024 | Oct 30, 2024 · pre-market | Oct 30, 2024 | ||||||
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | Feb 6, 2024 · pre-market | Feb 6, 2024 | 37 d | 10-K | $5.21B | +5.4% | — | |
| Q3 2023 | Sep 30, 2023 | Oct 31, 2023 · pre-market | Oct 31, 2023 | ||||||
| FY 2022 | |||||||||
| Q4 2022derived | Dec 31, 2022 | Jan 30, 2023 · pre-market | Feb 15, 2023 | 46 d | 10-K | $4.94B | — | — | |
| Q3 2022 | Sep 30, 2022 | — | — | ||||||
| $5.13B |
| +7.4% |
| $0.85 |
| 29 d |
| 10-Q |
| $5.14B |
| +5.8% |
| $0.98 |
| Q2 2025 | Jun 30, 2025 | Jul 30, 2025 · pre-market | Jul 30, 2025 | 30 d | 10-Q | $5.01B | +3.5% | $1.06 |
|---|
| Q1 2025 | Mar 31, 2025 | Apr 30, 2025 · pre-market | Apr 30, 2025 | 30 d | 10-Q | $4.78B | +2.7% | $1.23 |
|---|
| 30 d |
| 10-Q |
| $4.86B |
| +0.9% |
| $1.02 |
| Q2 2024 | Jun 30, 2024 | Jul 31, 2024 · pre-market | Jul 31, 2024 | 31 d | 10-Q | $4.84B | +0.5% | $0.93 |
|---|
| Q1 2024 | Mar 31, 2024 | Apr 30, 2024 · pre-market | Apr 30, 2024 | 30 d | 10-Q | $4.65B | −1.2% | $0.81 |
|---|
| 31 d |
| 10-Q |
| $4.82B |
| +5.4% |
| $0.82 |
| Q2 2023 | Jun 30, 2023 | Jul 25, 2023 · pre-market | Jul 25, 2023 | 25 d | 10-Q | $4.82B | +7.4% | $0.91 |
|---|
| Q1 2023 | Mar 31, 2023 | Apr 25, 2023 · pre-market | Apr 25, 2023 | 25 d | 10-Q | $4.71B | +8.4% | $0.41 |
|---|
| — |
| — |
| $4.58B |
| — |
| $1.07 |
| Q2 2022 | Jun 30, 2022 | — | — | — | — | $4.48B | — | $1.07 |
|---|
| Q1 2022 | Mar 31, 2022 | — | — | — | — | $4.34B | — | $0.86 |
|---|
